Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr;6(2):101-104.
doi: 10.21037/hbsn.2017.01.02.

Epidemiology and risk factors: intrahepatic cholangiocarcinoma

Affiliations
Review

Epidemiology and risk factors: intrahepatic cholangiocarcinoma

Amar Gupta et al. Hepatobiliary Surg Nutr. 2017 Apr.

Abstract

Intrahepatic cholangiocarcinoma (ICC) is a rare entity with a distinct clinical course and epidemiology from hilar and extrahepatic cholangiocarcinoma. ICC makes up 8-10% of cholangiocarcinomas and 10-20% of all primary liver tumors. There remains a considerable amount of geographic variation in the incidence of ICC worldwide; however, the overall incidence of this malignancy appears to be rising. Several risk factors have been identified, such as infectious causes (liver flukes, viral hepatitis), biliary tract disease [primary sclerosing cholangitis (PSC), hepaticolithiasis, biliary cystic diseases], metabolic syndrome, lifestyle choices (alcohol abuse, tobacco use), and cirrhosis. Despite this, a substantial number of ICC patients do not have any identifiable risk factors, underlining the need for further work into the pathogenesis of this malignancy.

Keywords: Intrahepatic cholangiocarcinoma (ICC); epidemiology; risk factors.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

References

    1. Maithel SK, Gamblin TC, Kamel I, et al. Multidisciplinary approaches to Intrahepatic cholangiocarcinoma. Cancer 2013;119:3929-42. 10.1002/cncr.28312 - DOI - PubMed
    1. DeOliveira ML, Cunningham SC, Cameron JL, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 2007;245:755-62. 10.1097/01.sla.0000251366.62632.d3 - DOI - PMC - PubMed
    1. Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet 2014;383:2168-79. 10.1016/S0140-6736(13)61903-0 - DOI - PMC - PubMed
    1. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004;24:115-25. 10.1055/s-2004-828889 - DOI - PubMed
    1. Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for Intrahepatic cholangiocarcinoma. J Hepatol 2012;57:69-76. 10.1016/j.jhep.2012.02.022 - DOI - PMC - PubMed

LinkOut - more resources